West Nile virus encephalomyelitis with polio-like paralysis & nigral degeneration

Canadian Journal of Neurological Sciences

Volumn 33, Issue 4, 2006, Pages 407-410

  Schafernak, Kristian T ^a   Bigio, Eileen H ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CEFTRIAXONE; VANCOMYCIN;

ADULT; ANAMNESIS; ARTICLE; AUTOPSY; BRAIN DEGENERATION; CASE REPORT; CELL LOSS; CLINICAL FEATURE; ENCEPHALOMYELITIS; GLIOSIS; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; LUMBAR PUNCTURE; MALE; NERVE CELL; NEUROFIBRILLARY TANGLE; PARALYSIS; PHYSICAL EXAMINATION; POLIOMYELITIS; PRIORITY JOURNAL; SEROLOGY; SUBSTANTIA NIGRA; WEST NILE FLAVIVIRUS;

EID: 33845637637     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0317167100005370     Document Type: Article

References (26)

1. Mackenzie JS, Gubler DJ, Petersen LR. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat Med. 2004;10:S98-109.
2. Sejvar JJ, Haddad MB, Tierney BC, Campbell GL, Marfin AA, Van Gerpen JA, et al. Neurologic manifestations and outcome of West Nile virus infection. JAMA. 2003;290:511-5.
3. Omalu BI, Shakir AA, Wang G, Lipkin WI, Wiley CA. Fatal fulminant pan-meningo-polioencephalitis due to West Nile virus. Brain Pathol. 2003;13:465-72.
4. Leis AA, Stokic DS, Polk JL, Dostrow V, Winkelmann M. A poliomyelitis-like syndrome from West Nile virus infection. N Engl J Med. 2002;347:1279-80.
5. Glass JD, Samuels O, Rich MM. Poliomyelitis due to West Nile virus. N Engl J Med. 2002;347:1280-1.
6. Kelley TW, Prayson RA, Isada CM. Spinal cord disease in West Nile virus infection. N Engl J Med. 2003;348:564-6.
7. Jeha LE, Sila CA, Lederman RJ, Prayson RA, Isada CM, Gordon SM. West Nile virus infection: a new paralytic illness. Neurology. 2003;61:55-9.
8. Doron SI, Dashe JF, Adelman LS, Brown WF, Werner BG, Hadley S. Histopathologically proven poliomyelitis with quadriplegia and loss of brainstem function due to West Nile virus infection. Clin Infect Dis. 2003;37:e74-7.
9. Agamanolis DP, Leslie MJ, Caveny EA, Guarner J, Shieh W-J, Zaki SR. Neuropathological findings in West Nile virus encephalitis: a case report. Ann Neurol. 2003;54:547-51.
10. Fratkin JD, Leis AA, Stokic DS, Slavinski SA, Geiss RW. Spinal cord neuropathology in human West Nile virus infection. Arch Pathol Lab Med. 2004;128:533-7.
11. Heresi GP, Mancias P, Mazur LJ, Butler IJ, Murphy JR, Cleary TG. Poliomyelitis-like syndrome in a child with West Nile virus infection. Pediatr Infect Dis. 2004;23:788-9.
12. Robinson RL, Shahida S, Madan N, Rao S, Khardori N. Transient parkinsonism in West Nile virus encephalitis. Am J Med. 2003;115:252-3.
13. Burton JM, Kern RZ, Halliday W, Mikulis D, Brunton J, Fearon M, et al. Neurological manifestations of West Nile virus infection. Can J Neurol Sci. 2004;31:185-93.
14. Kleinschmidt-DeMasters BK, Marder BA, Levi ME, Laird SP, McNutt JT, Escott EJ, et al. Naturally acquired West Nile virus encephalomyelitis in transplant recipients: clinical, laboratory, diagnostic, and neuropathological features. Arch Neurol. 2004;61:1210-20.
15. Savant CS, Singhal BS, Jankovic J, Khan MAK, Virani A. Substantia nigra lesions in viral encephalitis. Mov Disord. 2003;18:213-6.
16. Pradhan S, Pandey N, Shashank S, Gupta RK, Mathur A. Parkinsonism due to predominant involvement of substantia nigra in Japanese encephalitis. Neurology. 1999;53:1781-6.
17. Cerna F, Mehrad B, Luby JP, Burns D, Fleckenstein JL. St. Louis encephalitis and the substantia nigra: MR imaging evaluation. Am J Neuroradiol. 1999;20:1281-3.
18. Wasay M, Diaz-Arrastia R, Suss RA, Kojan S, Haq A, Burns D, et al. St. Louis encephalitis: a review of 11 cases in a 1995 Dallas, Tex, epidemic. Arch Neurol. 2000;57:114-8.
19. Ogata A, Tashiro K, Nukuzuma S, Nagashima K, Hall WW. A rat model of Parkinson's disease induced by Japanese encephalitis virus. J Neurovirol. 1997;3:141-7.
20. Ogata A, Nagashima K, Yasui K, Matsuura T, Tashiro K. Sustained release dosage of thyrotropin-releasing hormone improves experimental Japanese encephalitis virus-induced parkinsonism in rats. J Neurol Sci. 1998;159:135-9.
21. Ogata A, Hamaue N, Terado M, Minami M, Nagashima K, Tashiro K. Isatin, an endogenous MAO inhibitor, improves bradykinesia and dopamine levels in a rat model of Parkinson's disease induced by Japanese encephalitis virus. J Neurol Sci. 2003;206:79-83.
22. Hamaue N, Minami M, Terado M, Hirafuji M, Endo T, Machida M, et al. Comparative study of the effects of isatin, an endogenous MAO-inhibitor, and selegiline on bradykinesia and dopamine levels in a rat model of Parkinson's disease induced by the Japanese encephalitis virus. Neurotoxicology. 2004;25:205-13.
23. Wong KT, Allen IV, McQuaid S, McConnell R. An immunohistochemical study of neurofibrillary tangle formation in post-encephalitic Parkinsonisrn. Clin Neuropathol. 1996;15:22-5.
24. Pramstaller PP, Lees AJ, Luxon LM. Possible clinical overlap between postencephalitic parkinsonism and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry. 1996;60:589-90.
25. Hudson AJ, Rice GP. Similarities of guamanian ALS/PD to post-encephalitic parkinsonism/ALS: possible viral causes. Can J Neurol Sci. 1990;17:427-33.
26. Hudson AJ. Amyotrophic lateral sclerosis/parkinsonism/dementia: clinicopathological correlations relevant to Guamanian ALS/PD. Can J Neurol Sci. 1991;18:387-9.